|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
2/27/23 Afeyan Noubar 4 Dir.,%Own.² 1:17K Omega Therapeutics, Inc. Donnelley Fin’l S… 06/FA
Flagship Pioneering Inc.
Flagship Pioneering Special Opportunities Fd II Gen’l Part… LLC
Flagship Pioneering Special Opportunities Fund II, L.P.
2/27/23 Flagship Pioneering Fd VII, L.P. 3 10% Owner² 1:6K Omega Therapeutics, Inc. Donnelley Fin’l S… 06/FA
Flagship Pioneering Fund VII General Partner LLC
2/27/23 Flagship Ventures Fund V, L.P. SC 13D/A 2:318K Omega Therapeutics, Inc. Donnelley … Solutions/FA
Flagship Pioneering Fund VI General Partner LLC³
Flagship Pioneering Fund VI, L.P.³
Flagship Pioneering Fund VII General Partner LLC³
Flagship Pioneering Fund VII, L.P.³
Flagship Pioneering Special Opportunities Fd II Gen’l P… LLC³
Flagship Pioneering Special Opportunities Fund II, L.P.³
Flagship Pioneering, Inc.³
Flagship V Venturelabs RX Fund, L.P.³
Flagship Venturelabs V, LLC³
Flagship Ventures Fund V General Partner LLC³
FPN General Partner LLC³
FPN, L.P.³
Noubar Afeyan³
Nutritional Health LTP Fund General Partner LLC³
Nutritional Health LTP Fund, L.P.³
Venturelabs V Manager LLC³
____________ | ¹ | Filing/Form Types: -K | | 3 | Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }. | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | | SC 13D | Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. | ³ | Group Member: A Registrant or non-Registrant party to this Filing made by a Group. |
|